Alaska Permanent Fund is a sovereign wealth fund in the United States. The entire Fund is managed as a single investment pool, and is invested in a range of assets including stocks, bonds and real estate.
801 West 10th Street
Alaska, United States
|2021-04-13||Repertoire Immune Medicines||Series B||$189M||Flagship Pioneering, Invus Group, Public Sector Pension Investment Board, SoftBank Group, and Undisclosed Investors|
|2021-01-12||Tessera Therapeutics||Series B||$230M||Altitude Life Science Ventures, Qatar Investment Authority, SAYA BIO, and SoftBank Group|
|2020-08-03||Indigo Ag||Convertible Note - II||$100M||Flagship Pioneering|
|2020-06-23||Sana Biotechnology||Series B - II||$481M||Altitude Life Science Ventures, Amity Ventures, ARCH Venture Partners, Baillie Gifford & Co., Bezos Expeditions, Biogen Idec New Ventures, CPP Investments, F-Prime Capital, Flagship Pioneering, Google Ventures, Omega Fund Management, Public Sector Pension Investment Board, and Undisclosed Investors|
|2020-06-23||Indigo Ag||Series F||$260M||Flagship Pioneering, and Riverstone Holdings|